ETC
UTHR icon

Exchange Traded Concepts’s United Therapeutics UTHR Stock Holding History

Exchange Traded Concepts’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
4,576
+78
+2% +$43.9K 0.01% 639
2026
Q1 		$2.67M Sell
4,498
-366
-8% -$182K 0.02% 531
2025
Q4 		$2.37M Buy
4,864
+1,164
+31% +$542K 0.02% 546
2025
Q3 		$1.55M Sell
3,700
-787
-18% -$265K 0.01% 633
2025
Q2 		$1.29M Sell
4,487
-156
-3% -$46.6K 0.02% 590
2025
Q1 		$1.43M Buy
4,643
+581
+14% +$199K 0.02% 457
2024
Q4 		$1.43M Sell
4,062
-74
-2% -$27.2K 0.03% 465
2024
Q3 		$1.48M Sell
4,136
-1,162
-22% -$393K 0.03% 414
2024
Q2 		$1.69M Sell
5,298
-634
-11% -$168K 0.04% 342
2024
Q1 		$1.36M Buy
5,932
+3,187
+116% +$719K 0.04% 371
2023
Q4 		$604K Buy
2,745
+210
+8% +$48.4K 0.02% 554
2023
Q3 		$573K Sell
2,535
-119
-4% -$27.4K 0.02% 545
2023
Q2 		$586K Buy
2,654
+105
+4% +$23.3K 0.01% 550
2023
Q1 		$571K Sell
2,549
-284
-10% -$70K 0.02% 520
2022
Q4 		$788K Buy
2,833
+75
+3% +$18.9K 0.02% 340
2022
Q3 		$577K Sell
2,758
-229
-8% -$51.2K 0.02% 403
2022
Q2 		$704K Buy
2,987
+68
+2% +$13.8K 0.02% 354
2022
Q1 		$524K Buy
2,919
+86
+3% +$16.4K 0.01% 626
2021
Q4 		$612K Sell
2,833
-160
-5% -$31.4K 0.01% 526
2021
Q3 		$552K Buy
2,993
+49
+2% +$9.65K 0.01% 503
2021
Q2 		$528K Sell
2,944
-154
-5% -$29.3K 0.02% 522
2021
Q1 		$518K Sell
3,098
-101
-3% -$16.8K 0.02% 453
2020
Q4 		$486K Buy
3,199
+313
+11% +$41.1K 0.02% 366
2020
Q3 		$291K Buy
2,886
+178
+7% +$19.5K 0.02% 478
2020
Q2 		$328K Buy
+2,708
New +$305K 0.05% 304

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Exchange Traded Concepts's UTHR Position: Q2 2026 in Review

Exchange Traded Concepts increased its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, buying an estimated $43.9K and bringing the position to 4,576 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #639.

Exchange Traded Concepts first reported a position in UTHR in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.67M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Exchange Traded Concepts held 4,576 shares of United Therapeutics worth $2.48M as of Q2 2026.
  • Exchange Traded Concepts bought 78 United Therapeutics shares in Q2 2026, an estimated $43.9K.
  • United Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #639 holding.
  • Exchange Traded Concepts first reported a position in United Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Exchange Traded Concepts's United Therapeutics position peaked at $2.67M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.